CN102406806B - Traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and preparation method thereof - Google Patents

Traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and preparation method thereof Download PDF

Info

Publication number
CN102406806B
CN102406806B CN 201110343411 CN201110343411A CN102406806B CN 102406806 B CN102406806 B CN 102406806B CN 201110343411 CN201110343411 CN 201110343411 CN 201110343411 A CN201110343411 A CN 201110343411A CN 102406806 B CN102406806 B CN 102406806B
Authority
CN
China
Prior art keywords
traditional chinese
chinese medicine
disease
chinese medicinal
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 201110343411
Other languages
Chinese (zh)
Other versions
CN102406806A (en
Inventor
谷刚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JINGZHONGSHAN SINOPHARM (TANGSHAN) Co.,Ltd.
Original Assignee
谷刚
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 谷刚 filed Critical 谷刚
Priority to CN 201110343411 priority Critical patent/CN102406806B/en
Publication of CN102406806A publication Critical patent/CN102406806A/en
Application granted granted Critical
Publication of CN102406806B publication Critical patent/CN102406806B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and a preparation method thereof. The traditional Chinese medicinal powder is prepared from 12 traditional Chinese medicinal materials such as nux vomica, dragon's blood, frankincense, myrrh, typhonium giganteum, ephedra, radix sileris, coptis root, baikal skullcap root, safflower, catechu and the like, and the sum of contents of the components is 100%. The traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung can be prepared by the steps of: removing impurities from weighed 12 traditional Chinese medicinal materials, cleaning and drying in the sun, mixing and pulverizing all the traditional Chinese medicinal materials by a traditional Chinese medicine pulverizer, mixing uniformly, and grinding the pulverized mixture into fine powder. The invention solves the problems of long treatment cycle, big side effect and high recurrence rate of the traditional Chinese medicine in the prior art, and high expense and big risk of surgical treatment, and the method disclosed by the invention has a simple preparation process and obvious effect.

Description

A kind of Chinese medicine powder for the treatment of obstructive and embolic lung disease and preparation method thereof
Technical field
The invention belongs to the Chinese medicine composition technical field, be specifically related to a kind of Chinese medicine powder for the treatment of obstructive and embolic lung disease, the invention still further relates to the preparation method of above-mentioned Chinese medicine powder.
Background technology
Obstructive and embolic lung disease all belong to respiratory system class disease, the number of patients showed increased of obstructive pulmonary disease in recent years, and sickness rate is higher, and the mortality rate that causes is also higher.Data according to World Health Organization (WHO) shows, because suffering from mortality rate shelter that obstructive pulmonary disease causes the 4th of the cause of the death arranged, obstructive pulmonary disease will become the 5th of world's disease financial burden according to estimates, also be the important respiratory system disease of serious harm people's health in China's obstructive pulmonary disease.Obstructive pulmonary disease is a kind of disease that can prevent and treat with flow limitation feature, not exclusively reversible being carried out sexual development to flow limitation, relevant to the abnormal inflammatory reaction of the harmful gas such as smoke from cigarette or deleterious particle with pulmonary, obstructive pulmonary disease mainly can be involved lungs, but also may cause the untoward reaction of whole body.
The embolic lung disease refers to that the caulked material enters pulmonary artery and branch thereof, and the blocking-up tissue blood is supplied caused pathology and clinical state.Common embolus is thrombosis, and all the other are the drug particles of rare new biological cell, fat drop, bubble, vein input even the vessel control that the conduit head end causes.The sickness rate of embolic lung disease is also very high in recent years, and the clinical manifestation of embolic lung disease can be from asymptomatic to sudden death.Common symptom is dyspnea and chest pain, and incidence rate all reaches more than 80%.Pleura pain is sent out suddenly the survivor and is generally the lung infraction for due to the contiguous pleura cellulose inflammation.Diaphragmatic pleura is got involved and can be produced retrosternal pain to shoulder or abdominal part radiation, quite like myocardial infarction, spits blood sometimes.
Based on the harm of obstructive and embolic lung disease, must strengthen and pay attention to the treatment of this type of lung disease, delay the deterioration of pulmonary function, thereby alleviate slight illness for the patient.In case ill and don't adopt an effective measure, patient's pulmonary function will be faded, work capacity and the quality of life that also can have a strong impact on the patient that have.Also have some patients after acute attack stage, though clinical symptoms is alleviated to some extent, its pulmonary function is still continuing deterioration, and because self-defense and the reduction of immunologic function and the impact of extraneous various harmful factors, often repeatedly outbreak, and produce gradually various Cardiopulmonary Complications.
The method for the treatment of obstructive and embolic lung disease mainly is divided into two large classes at present: a class is Drug therapy; Another kind of is surgical operation therapy.It is long that but existing most drug treatment continues the cycle, and drug variety is various, and side effect is large, and what have can only the respite symptom can't effect a radical cure.And higher for doctor's specification requirement when adopting surgical operation therapy, exist operation risk large, cost is high, health is had the shortcomings such as wound.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine powder for the treatment of obstructive and embolic lung disease, solved that existing Chinese medicine treatment cycle is long, side effect is large, easily recurrence, and the surgical operation therapy expense is high, the problem that has a big risk.
Another object of the present invention provides the preparation method of above-mentioned composition.
The technical solution adopted in the present invention is,
A kind of Chinese medicine powder for the treatment of obstructive and embolic lung disease is mainly used in treating obstructive and embolic lung disease.Active component by following raw material forms by mass percentage:
Semen Strychni 15-24%, Sanguis Draxonis 4-7%, Olibanum 4-8%, Myrrha 3-6%, Herba Typhonii gigantei 9-13%, Herba Ephedrae 8-12%, Radix Saposhnikoviae 7-10%, Rhizoma Coptidis 7-14%, Radix Scutellariae 8-14%, Flos Carthami 3-6%, catechu 3-6%, Radix Glycyrrhizae 2-4%, the content summation of above component is 100%.
The mass percent of described Chinese medicine ingredients is preferably: Semen Strychni 20%, and Sanguis Draxonis 5%, Olibanum 6%, Myrrha 4%, Herba Typhonii gigantei 11%, Herba Ephedrae 10%, Radix Saposhnikoviae 9%, Rhizoma Coptidis 11%, Radix Scutellariae 11%, Flos Carthami 5%, catechu 5%, Radix Glycyrrhizae 3%, the content summation of above component is 100%.
Another technical scheme of the present invention is, the preparation method of this Chinese medicine powder is carried out according to following steps:
Step 1, the weighing medicine,
Take by weighing respectively by mass percentage
Semen Strychni 15-24%, Sanguis Draxonis 4-7%, Olibanum 4-8%, Myrrha 3-6%, Herba Typhonii gigantei 9-13%, Herba Ephedrae 8-12%, Radix Saposhnikoviae 7-10%, Rhizoma Coptidis 7-14%, Radix Scutellariae 8-14%, Flos Carthami 3-6%, catechu 3-6%, Radix Glycyrrhizae 2-4%, the content summation of above component is 100%.
Step 2 is washed the solarization medicine,
With the load weighted Chinese crude drug Semen Strychni of step 1, Sanguis Draxonis, Olibanum, Myrrha, Herba Typhonii gigantei, Herba Ephedrae, Radix Saposhnikoviae, Rhizoma Coptidis, Radix Scutellariae, Flos Carthami, catechu, the Radix Glycyrrhizae removal of contamination is cleaned, is dried;
Step 3 is concocted,
To mix through all medicines that step 2 is processed, with Chinese medicine grinder all Chinese medicines are pulverized and mix homogeneously, the mixture after will pulverizing again grinds to form fine powder together, namely can be made into the Chinese medicine powder for the treatment of obstructive and embolic lung disease.
The invention has the beneficial effects as follows, the treatment obstructive that employing the inventive method makes and the Chinese medicine powder of embolic lung disease are pure oral preparation of Chinese traditional medicinal, to treat chronic or acute occlusion lung disease and embolic lung disease curative effect very remarkable, use also very convenient, only need to get final product with warm water delivery service, overcome that existing medicine is large in the side effect that exists aspect treatment obstructive and the embolic lung disease, cure rate is low, easy recurrence, shortcoming that treatment cycle is long, also avoided the problem that the surgical operation therapy expense is high, have a big risk.The Chinese medicine powder that the present invention makes has the advantage that therapeutic effect is obvious, cure rate is high, be difficult for recurrence, almost non-toxic side effect by clinical verification aspect treatment obstructive and the embolic lung disease.
The specific embodiment
The present invention is described in detail below in conjunction with specific embodiment.
A kind of Chinese medicine powder for the treatment of obstructive and embolic lung disease, the active component by following raw material forms by mass percentage:
Semen Strychni 15-24%, Sanguis Draxonis 4-7%, Olibanum 4-8%, Myrrha 3-6%, Herba Typhonii gigantei 9-13%, Herba Ephedrae 8-12%, Radix Saposhnikoviae 7-10%, Rhizoma Coptidis 7-14%, Radix Scutellariae 8-14%, Flos Carthami 3-6%, catechu 3-6%, Radix Glycyrrhizae 2-4%, the content summation of above component is 100%.
One, function and the function of each raw material in this medicine cures mainly:
Semen Strychni: cold in nature, bitter in the mouth, removing obstruction in the collateral to relieve pain, mass dissipating and swelling eliminating is used for rheumatoid arthritis stubborn, and paralysis and numbness, injury from falling down can make the venation of thromboembolism strengthen wriggling, are mainly used in controlling wound pain caused by ecchymoma and ulcer sore pain.
Sanguis Draxonis: warm in nature, sweet in the mouth, suffering, salty, promoting blood circulation to remove blood stasis, the analgesic therapy hemostasis is scattered for congestion and the blood stasis that will condense in blood vessel.
Olibanum: slightly warm in nature, acrid in the mouth, hardship; Blood circulation promoting and blood stasis dispelling, detumescence and promoting granulation, inducing menstruation to relieve menalgia.Be used for unimpeded blood vessels.
Myrrha: property is flat, bitter in the mouth, suffering, promoting blood circulation and stopping pain, removing blood stasis to reduce swelling, detumescence and promoting granulation.Be used for blood circulation promoting and blood stasis dispelling, unimpeded blood vessels.
Herba Typhonii gigantei: warm in nature, acrid in the mouth, sweet, the saliva that eliminates the phlegm, clear pertinacious phlegm, degassing cooperate Sanguis Draxonis to accelerate to eliminate the phlegm desilting blood, with Sanguis Draxonis be ministerial drug altogether.
Herba Ephedrae: warm in nature, acrid in the mouth, little hardship, diaphoresis cold expelling, depressed lung-energy dispersing, inducing diuresis to remove edema.
Radix Saposhnikoviae: slightly warm in nature, acrid in the mouth, sweet, expelling pathogenic wind from the body surface, removing dampness to relieve pain cures mainly the diseases caused by exogenous pathogenic factor exterior syndrome, rubella pruritus, rheumatic arthralgia, tetanus.
Rhizoma Coptidis: cold in nature, bitter in the mouth, heat clearing and damp drying, eliminating fire and detoxication.Be used for damp and hot feeling of fullness, the vomiting acid regurgitation, dysentery, jaundice, unconsciousness due to high fever, hyperactivity of heart-fire, dysphoria and insomnia, heat in blood is told nosebleed, conjunctival congestion, the carbuncle furuncle is quenched one's thirst in toothache.
Radix Scutellariae: cold in nature, bitter in the mouth, heat clearing and damp drying, eliminating fire and detoxication, hemostasis, blood pressure lowering.Be used for hygropyrexia, fever disease in summer vomiting and nausea uncomfortable in chest, damp and hot feeling of fullness, the cough due to lung-heat, high hot excessive thirst, heat in blood is told nosebleed, carbuncle sore tumefacting virus.
Flos Carthami: blood circulation promoting and blood stasis dispelling, the latus rectum of invigorating blood circulation, removing obstruction in the collateral to relieve pain, eliminating stasis to stop pain, multiplex removing blood stasis, few with nourishing blood, adopt a small amount of being used for to nourish blood in this prescription.
Catechu: cold nature, bitter in the mouth, puckery, blood circulation promoting and blood stasis dispelling, unobstructed blood vessels.
Radix Glycyrrhizae: property is flat, sweet in the mouth, invigorating the spleen and replenishing QI, expelling phlegm for arresting cough, relieving spasm to stop pain, heat-clearing and toxic substances removing, coordinating the actions of various ingredients in a prescription.
Two, preparation method and usage, consumption
The preparation method of Chinese medicine powder of the present invention, carry out according to following steps:
Step 1, the weighing medicine,
Take by weighing respectively by mass percentage
Semen Strychni 15-24%, Sanguis Draxonis 4-7%, Olibanum 4-8%, Myrrha 3-6%, Herba Typhonii gigantei 9-13%, Herba Ephedrae 8-12%, Radix Saposhnikoviae 7-10%, Rhizoma Coptidis 7-14%, Radix Scutellariae 8-14%, Flos Carthami 3-6%, catechu 3-6%, Radix Glycyrrhizae 2-4%, the content summation of above component is 100%.
Step 2 is washed the solarization medicine,
With the load weighted Chinese crude drug Semen Strychni of step 1, Sanguis Draxonis, Olibanum, Myrrha, Herba Typhonii gigantei, Herba Ephedrae, Radix Saposhnikoviae, Rhizoma Coptidis, Radix Scutellariae, Flos Carthami, catechu, the Radix Glycyrrhizae removal of contamination is cleaned, is dried;
Step 3 is concocted,
To mix through the Chinese crude drug that step 2 is processed, with Chinese medicine grinder all Chinese crude drugs are pulverized and mix homogeneously, the mixture after will pulverizing again grinds to form fine powder together, namely makes the Chinese medicine powder for the treatment of obstructive and embolic lung disease.
The usage of Chinese medicine powder of the present invention and consumption generally directly get final product Chinese medicine powder during use with water delivery service, one day three times, each serving using 0.3g, general one month just can take effect.
Three, Clinic Case
Through for many years, the clinical practice to hundreds of routine arthralgias and osteodynia disease has obtained good therapeutic effect, and its remarkable efficient can reach more than 95%, and relevant clinical treatment situation is as follows in detail:
Ma, man 46 years old examined in October, 2005.Asthma uncomfortable in chest, heart beating is nervous, has a surplus in ill 3 years.3 years causes and people quarrel anger, spit blood at that time, rear palpitation and short breath, come medical before the state of an illness comparatively serious.Learn that from above symptom the embolic lung disease forms.Take Chinese medicine powder of the present invention, every day three times, each 0.3g serve on January, and the nervous symptom of asthma disappears substantially, continues again to cure in 20 days for oral use.
High certain, man 49 years old examined in August, 2006.Readme: often cough, existing more than 5 years, recent months, cough is spat with the atropurpureus clot, has a few days ago told several mouthfuls of blood, goes to hospital to take the injection hemostasis.Suddenly look for Chinese traditional treatment after the hemostasis.The patient had in the past and time exerted oneself too quicklyly, and second day is just felt dyspnea (feeling suffocated a little), and cough develops into present state then.Take Chinese medicine powder of the present invention, every day three times, each 0.3g serve on January, and the cough symptom of breathing hard disappears substantially, takes and cures January.
Gong, woman 40 years old was in first visit in 2008.Uncomfortable in chest from the speech nasal obstruction, dyspnea is before 3 years, because the heavy cold hospitalization is had a surplus January, the flu of having a cold again after leaving hospital is after the healing, have a hunch to breathe to have some setbacks that it is more and more serious to have a stuffy nose, this symptom belongs to obstructive pulmonary disease, take Chinese medicine powder of the present invention, every day three times, each 0.3g, sx↓ after 10 days, took medicine 10 days, transference cure continues to take and cured fully in 10 days again.
Above patient takes Chinese medicine powder of the present invention, toxic and side effects and any untoward reaction all do not occur.
Semen Strychni is the meridian dredging good medicine in this Chinese medicine powder, can make the venation of thromboembolism strengthen wriggling and be monarch drug, is that to calculate consumption for the medicine that main disease plays a major role by mass percent be 20%.The Sanguis Draxonis mass percent is 5% can promoting blood circulation to remove blood stasis, and the congestion and the blood stasis that condense in blood vessel are scattered.The Herba Typhonii gigantei mass percent is 11% can be used for eliminating the phlegm saliva, clear pertinacious phlegm, degassing, cooperates Sanguis Draxonis can accelerate the desilting blood that eliminates the phlegm, and Herba Typhonii gigantei and Sanguis Draxonis be ministerial drug altogether, and auxiliary monarch drug Semen Strychni is strengthened treatment master disease.The Olibanum mass percent is 6%, Myrrha is 4%, catechu is 5%, and this three flavors medical material is adjuvant drug, can play the effect of blood circulation promoting and blood stasis dispelling, unobstructed blood vessels.Herba Ephedrae mass percent 10%, Radix Saposhnikoviae are that 9% liang of flavor medical material is used can be in order to inducing sweat, lung governing skin and hair, and pathogenic heat is passed through inside by fur in the lung, can prevent that again the cold-evil from restrainting lung.The mass percent of Rhizoma Coptidis and Radix Scutellariae is 11%, is used the fire of the cardiopulmonary of can dispelling (these sick most lung-fire of having the inclination).Flos Carthami is generally few with nourishing blood, multiplex removing blood stasis, and the employing mass percent is 5% in this prescription, in order to nourish blood.Radix Glycyrrhizae has the title of " state is old ", in order to be in harmonious proportion other drug, cooperates with Flos Carthami to share in this medicated powder, and centralizing function nourishes blood.
Embodiment 1
Take by weighing respectively by mass percentage Semen Strychni 15%, Sanguis Draxonis 4%, Olibanum 4%, Myrrha 6%, Herba Typhonii gigantei 9%, Herba Ephedrae 8%, Radix Saposhnikoviae 10%, Rhizoma Coptidis 14%, Radix Scutellariae 14%, Flos Carthami 6%, catechu 6%, Radix Glycyrrhizae 4%, the content summation of above component is 100%.With load weighted Chinese crude drug Semen Strychni, Sanguis Draxonis, Olibanum, Myrrha, Herba Typhonii gigantei, Herba Ephedrae, Radix Saposhnikoviae, Rhizoma Coptidis, Radix Scutellariae, Flos Carthami, catechu, the Radix Glycyrrhizae removal of contamination is cleaned, is dried, mix and with Chinese medicine grinder all Chinese medicines are pulverized and mix homogeneously afterwards, the mixture after will pulverizing again grinds to form fine powder together, namely can be made into the Chinese medicine powder for the treatment of obstructive and embolic lung disease.
Embodiment 2
Take by weighing respectively by mass percentage Semen Strychni 18%, Sanguis Draxonis 5%, Olibanum 6%, Myrrha 5%, Herba Typhonii gigantei 11%, Herba Ephedrae 10%, Radix Saposhnikoviae 9%, Rhizoma Coptidis 12%, Radix Scutellariae 12%, Flos Carthami 4%, catechu 5%, Radix Glycyrrhizae 3%, the content summation of above component is 100%.With load weighted Chinese crude drug Semen Strychni, Sanguis Draxonis, Olibanum, Myrrha, Herba Typhonii gigantei, Herba Ephedrae, Radix Saposhnikoviae, Rhizoma Coptidis, Radix Scutellariae, Flos Carthami, catechu, the Radix Glycyrrhizae removal of contamination is cleaned, is dried, mix and with Chinese medicine grinder all Chinese medicines are pulverized and mix homogeneously afterwards, the mixture after will pulverizing again grinds to form fine powder together, namely can be made into the Chinese medicine powder for the treatment of obstructive and embolic lung disease.
Embodiment 3
Take by weighing respectively by mass percentage Semen Strychni 20%, Sanguis Draxonis 5%, Olibanum 6%, Myrrha 4%, Herba Typhonii gigantei 11%, Herba Ephedrae 10%, Radix Saposhnikoviae 9%, Rhizoma Coptidis 11%, Radix Scutellariae 11%, Flos Carthami 5%, catechu 5%, Radix Glycyrrhizae 3%, the content summation of above component is 100%.With load weighted Chinese crude drug Semen Strychni, Sanguis Draxonis, Olibanum, Myrrha, Herba Typhonii gigantei, Herba Ephedrae, Radix Saposhnikoviae, Rhizoma Coptidis, Radix Scutellariae, Flos Carthami, catechu, the Radix Glycyrrhizae removal of contamination is cleaned, is dried, mix and with Chinese medicine grinder all Chinese medicines are pulverized and mix homogeneously afterwards, the mixture after will pulverizing again grinds to form fine powder together, namely can be made into the Chinese medicine powder for the treatment of obstructive and embolic lung disease.
Embodiment 4
Take by weighing respectively by mass percentage Semen Strychni 24%, Sanguis Draxonis 7%, Olibanum 8%, Myrrha 6%, Herba Typhonii gigantei 13%, Herba Ephedrae 8%, Radix Saposhnikoviae 8%, Rhizoma Coptidis 7%, Radix Scutellariae 8%, Flos Carthami 3%, catechu 5%, Radix Glycyrrhizae 2%, the content summation of above component is 100%.With load weighted Chinese crude drug Semen Strychni, Sanguis Draxonis, Olibanum, Myrrha, Herba Typhonii gigantei, Herba Ephedrae, Radix Saposhnikoviae, Rhizoma Coptidis, Radix Scutellariae, Flos Carthami, catechu, the Radix Glycyrrhizae removal of contamination is cleaned, is dried, mix and with Chinese medicine grinder all Chinese medicines are pulverized and mix homogeneously afterwards, the mixture after will pulverizing again grinds to form fine powder together, namely can be made into the Chinese medicine powder for the treatment of obstructive and embolic lung disease.

Claims (2)

1. Chinese medicine powder for the treatment of obstructive and embolic lung disease is characterized in that the active component by following raw material forms by mass percentage:
Semen Strychni 15-24%, Sanguis Draxonis 4-7%, Olibanum 4-8%, Myrrha 3-6%, Herba Typhonii gigantei 9-13%, Herba Ephedrae 8-12%, Radix Saposhnikoviae 7-10%, Rhizoma Coptidis 7-14%, Radix Scutellariae 8-14%, Flos Carthami 3-6%, catechu 3-6%, Radix Glycyrrhizae 2-4%, the content summation of above component is 100%.
2. the preparation method of the described Chinese medicine powder of claim 1 is characterized in that, carries out according to following steps:
Step 1, the weighing medicine,
Take by weighing respectively by mass percentage:
Semen Strychni 15-24%, Sanguis Draxonis 4-7%, Olibanum 4-8%, Myrrha 3-6%, Herba Typhonii gigantei 9-13%, Herba Ephedrae 8-12%, Radix Saposhnikoviae 7-10%, Rhizoma Coptidis 7-14%, Radix Scutellariae 8-14%, Flos Carthami 3-6%, catechu 3-6%, Radix Glycyrrhizae 2-4%, the content summation of above component is 100%;
Step 2 is washed the solarization medicine,
With the load weighted Chinese crude drug Semen Strychni of step 1, Sanguis Draxonis, Olibanum, Myrrha, Herba Typhonii gigantei, Herba Ephedrae, Radix Saposhnikoviae, Rhizoma Coptidis, Radix Scutellariae, Flos Carthami, catechu, the Radix Glycyrrhizae removal of contamination is cleaned, is dried;
Step 3 is concocted,
To mix through the Chinese crude drug that step 2 is processed, with Chinese medicine grinder mixture is pulverized and mix homogeneously, the mixture after will pulverizing again grinds to form fine powder, namely makes the Chinese medicine powder for the treatment of obstructive and embolic lung disease.
CN 201110343411 2011-11-03 2011-11-03 Traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and preparation method thereof Active CN102406806B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110343411 CN102406806B (en) 2011-11-03 2011-11-03 Traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110343411 CN102406806B (en) 2011-11-03 2011-11-03 Traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and preparation method thereof

Publications (2)

Publication Number Publication Date
CN102406806A CN102406806A (en) 2012-04-11
CN102406806B true CN102406806B (en) 2013-04-10

Family

ID=45909342

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110343411 Active CN102406806B (en) 2011-11-03 2011-11-03 Traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and preparation method thereof

Country Status (1)

Country Link
CN (1) CN102406806B (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1141116C (en) * 2000-11-06 2004-03-10 曾广财 Powdered medicine for treating pulmonary tuberculosis

Also Published As

Publication number Publication date
CN102406806A (en) 2012-04-11

Similar Documents

Publication Publication Date Title
CN102743737B (en) Chinese medicinal preparation for effectively treating tracheitis
CN103110730B (en) Perillaseed-radix scutellariae-almond decoction for treating asthma and preparation method thereof
CN101024025A (en) Oral Chinese medicine composition for treating chronic bronchitis
CN103830636A (en) Pharmaceutical composition for treating bronchitis and asthma
CN102085301B (en) Traditional Chinese medicine composition for treating asthma, chronic bronchitis and tracheitis through acupuncture points
CN103623372A (en) Medicine for treating trachitis
CN102772650A (en) Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof
CN105434952A (en) Medicine for treating scarlatina and preparation method thereof
CN103989973A (en) Traditional Chinese medicine composition for treating cardiac asthma
CN102406806B (en) Traditional Chinese medicinal powder for treating obstructive disease and embolic disease of lung and preparation method thereof
CN107582834A (en) A kind of Chinese medicine composition for treating empty asthma
CN106109904A (en) One treats phthisical Chinese medicine and preparation method thereof
CN106110244A (en) Powder for relieving cough and asthma
CN104815143A (en) Traditional Chinese medicine composition for promoting children asthma health, and preparation method thereof
CN104906439A (en) Medicine for treating chronic respiratory failure
CN104784384A (en) Traditional Chinese medicine for treating pharyngitis
CN102133318B (en) Chinese medicinal preparation for treating bronchial asthma
CN104258231A (en) Traditional Chinese medicine composition for treating cough
CN102293888A (en) Chinese medicinal composition for treating syndrome characterized by dyspnea
CN108452279A (en) A kind of Chinese medicine composition and the preparation method and application thereof for treating flu
CN102961681A (en) Chinese patent medicine for treating viral myocarditis
CN108159219A (en) A kind of Chinese medicine for treating asthma in children
CN101961453A (en) Chinese medicament for treating chronic rhinitis
CN107929506A (en) A kind of capsule medicine and preparation method that can effectively treat bronchial asthma
CN107375508A (en) A kind of decoction medicine and preparation method for being used to treat chronic bronchitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right

Effective date of registration: 20200728

Address after: 063000 No.136 Park Road, Fengrun District, Tangshan City, Hebei Province

Patentee after: JINGZHONGSHAN SINOPHARM (TANGSHAN) Co.,Ltd.

Address before: 727505 Yanan City, Shaanxi province Fu Xian Zhang Jia Wan Zhen Yang Jia Wan Xing Zheng Cun five Shop No. 28

Patentee before: Gu Gang

TR01 Transfer of patent right